References
- Arbyn M, Benoy I, Simoens C, et al (2009). Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium. Cancer Epidemiol Biomarkers Prev, 18, 321-30. https://doi.org/10.1158/1055-9965.EPI-08-0510
- Bureau of Policy and Strategy. Ministry of public health Thailand. Available at http://ghdx.healthdata.org/record/thailand-public-health-statistics-2009. Accessed on October 10, 2015.
- Bruni L, Diaz M, Castellsague X, et al (2010). Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis, 202, 1789-99. https://doi.org/10.1086/657321
- Chandeying V, Garland SM, Tabrizi SN (2006). Prevalence and typing of human papillomavirus (HPV) among female sex workers and outpatient women in southern Thailand. Sex Health, 3, 11-4. https://doi.org/10.1071/SH05019
- Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, et al (2010). Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev, 11, 117-22.
- Chomsevi K, Jatuparisuth N(2002). Abnormal Pap smear of the uterine cervix at BMA general hospital. Vajira Med J, 46, 97-104.
- Cuzick J, Szarewski A, Cubie H, et al (2003). Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet, 362, 1871-6. https://doi.org/10.1016/S0140-6736(03)14955-0
- de Sanjose S, Diaz M, Castellsague X, et al (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis, 7, 453-9. https://doi.org/10.1016/S1473-3099(07)70158-5
- Ferreccio C, Barriga MI, Lagos M, et al (2013). Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile. Int J Cancer, 132, 916-23. https://doi.org/10.1002/ijc.27662
- Franceschi S, Herrero R, Clifford GM, et al (2006). Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer, 119, 2677-84. https://doi.org/10.1002/ijc.22241
- Insinga RP, Glass AG, Rush BB (2004). Diagnoses and outcomes in cervical cancer screening: A population-based study. Am J Obstet Gynecol, 191, 105-13. https://doi.org/10.1016/j.ajog.2004.01.043
- International Agency for Research on Cancer. Population fact sheets. Available at http://globocan.iarc.fr/Pages/fact_sheets_population.aspx (2012). Accessed on October 18, 2015.
- Kantathavorn N, Mahidol C, Sritana N, et al (2015). Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs. Infect Agent Cancer, 10, 7. https://doi.org/10.1186/s13027-015-0001-5
- Leinonen M, Kotaniemi-Talonen L, Anttila A, et al (2008). Prevalence of oncogenic human papilloma virus infection in an organised screening population in Finland. Int J Cancer, 123, 1344-9. https://doi.org/10.1002/ijc.23670
- Li J, Huang R, Schmidt JE, Qiao YL (2013). Epidemiological features of human papillomavirus (HPV) infection among women living in mainland China. Asian Pac J Cancer Prev, 14, 4015-23. https://doi.org/10.7314/APJCP.2013.14.7.4015
- Moore MA, Attasara P, Khuhaprema T, et.al (2010). Cancer epidemiology in mainland South-East Asia - past, present and future. Asian Pac J Cancer Prev, 11, 67-80.
- Munoz N, Hernandez-Suarez G, Mendez F, et al (2009). Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer, 100, 1184-90. https://doi.org/10.1038/sj.bjc.6604972
- Parkin DM, Louie KS, Clifford G (2008). Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine, 26, 1-16.
- Rugpao S, Koonlertkit S, Ruengkrist T, et al (2009). ThinPrep Pap-smear and cervical intraepithelial neoplasia in reproductive-aged Thai women. J Obstet Gynaecol Res, 35, 551-4. https://doi.org/10.1111/j.1447-0756.2008.00566.x
- Siriaunkgul S, Settakorn J, Sukpan K, et al (2014). Populationbased cervical cancer screening using high-risk HPV DNA test and liquid-based cytology in northern Thailand. Asian Pac J Cancer Prev, 15, 6837-42. https://doi.org/10.7314/APJCP.2014.15.16.6837
- Sukvirach S, Smith JS, Tunsakul S, et al (2003). Populationbased human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis, 187, 1246-56. https://doi.org/10.1086/373901
- Swangvaree SS, Kongkaew P, Rugsuj P, Saruk O (2010). Prevalence of high-risk human papillomavirus infection and cytologic results in Thailand. Asian Pac J Cancer Prev, 11, 1465-8.
- Wright TC Jr, Massad LS, Dunton CJ, et al (2007). 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis, 11, 201-22. https://doi.org/10.1097/LGT.0b013e3181585870
- Zhao FH, Zhu FC, Chen W, et al (2014). HPV-039 study group: Baseline prevalence and type distribution of human papillomavirus in healthy 20 Chinese women aged 18-25 years enrolled in a clinical trial. Int J Cancer, 135, 2604-11. https://doi.org/10.1002/ijc.28896
- Zorzi M, Del Mistro A, Farruggio A, et al (2013). Use of a highrisk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study. BJOG, 120, 1260-7. https://doi.org/10.1111/1471-0528.12272